We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPLP.L Regulatory News (PLP)

  • There is currently no data for PLP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

31 May 2016 16:22

RNS Number : 7868Z
Polypipe Group PLC
31 May 2016
 

 

 

Polypipe Group plc (the "Company")

Notification of Transaction by Persons

Discharging Managerial Responsibilities

Pursuant to the notification obligations under Disclosure and Transparency Rule 3.1.4R, the Company hereby notifies the following change in the interests of directors and persons discharging managerial responsibility ("PDMRs") in Ordinary Shares of £0.001 each in the Company ("Shares").

Grant of Long Term Incentive Plan award

The Company confirms that on 31 May 2016, in accordance with its shareholder approved Remuneration Policy and to align the interests of the Senior Management Team with shareholders, it granted to the following PDMR an award (structured as a nil-cost option) under the rules of the Polypipe Group plc 2014 Long Term Incentive Plan (the "LTIP"). This award, which has been granted in respect of the financial year beginning on 1 January 2016, is over the following maximum number of Shares in the Company:

Name/Position

 

Maximum number of Shares

Market value of Shares awarded

Martin Payne/Chief Financial Officer

77,743

£250,800 (88% of salary*)

*the LTIP has been reduced from 100% of salary on a pro-rata basis to reflect the part of the 2016 financial year which has elapsed prior to Mr. Payne commencing employment with the Company.

The vesting of this award is subject to the satisfaction of the following performance conditions, both of which will be measured over a three year performance period:

1. 25% of the maximum potential award is based on a Total Shareholder Return (the "TSR element") performance condition with a threshold of 25% of the TSR element reached on achieving median and 100% for achieving upper quartile performance relative to the Total Shareholder Return of the companies in a comparator group (consisting of companies in the FTSE 250 Index that are classified as Industrials by the Industry Classification Benchmark) and;

 

2. 75% of the maximum potential award is based on an Earnings per Share performance condition (the "EPS element") measured on a cumulative diluted basis with cumulative targets equivalent to growth of 5% p.a. required to reach the minimum threshold of 25% and 12% p.a. growth to reach the maximum of 100% against 2015 performance restated as to include a full year of Nuaire's contribution to earnings.

Subject to the satisfaction of the performance conditions the awards will normally vest on 31 May 2019 and remain exercisable until the tenth anniversary of the grant date.

Grant of other share awards

In addition, certain buy-out arrangements were agreed to partially compensate Martin Payne for bonus and long-term incentive awards which were forfeited when he left his previous employer Norcros plc. The buy-out arrangements were structured in accordance with the principles set out in our Policy, in particular that they should be of comparable commercial value to the incentives which have been forfeited.

 

The buy-out arrangements comprise:

 

3. A bonus payment of an estimated equivalent value to the bonus Mr Payne would have received from his previous employer in relation to the year of his departure. To provide alignment with shareholders, the compensatory bonus award was granted on 31 May 2016 wholly in the form of Polypipe shares (structured as a nil cost option) as set out below. These shares will vest in two equal tranches on the second and third anniversaries of Mr Payne's appointment subject to continued employment but no further performance conditions.

Number of Shares

Date of Vesting

24,900*

16 May 2018

24,900*

16 May 2019

*these elements qualify for additional shares in respect of the Company's dividends with a record date after the date Mr Payne commenced employment with the Company.

The number of shares awarded has been calculated using the average of the middle market closing price of the Company for the three dealing days starting on 25 May 2016.

4. An award of Polypipe shares (structured as a nil cost option) on 31 May 2016 of an estimated equivalent value to the shares Mr Payne would have received from his previous employer in relation to Approved Performance Share Plan (APSP) awards due to vest in 2016 and 2017 taking into account all relevant factors including time elapsed and performance to date for the APSP awards. The compensatory share award will vest on the same dates that the original APSP awards would have vested, subject to continued employment but no further performance conditions. No compensatory award was granted in respect of Mr Payne's APSP award due to vest in 2018.

Number of Shares

Date of Vesting

50,601

27 September 2016

23,684*

23 July 2017

*these elements qualify for additional shares in respect of the Company's dividends with a record date after the date Mr Payne commenced employment with the Company.

The number of shares awarded has been calculated using the average of the middle market closing prices of both the Company and Norcros plc for the three dealing days starting on 25 May 2016.

The buy-out awards will be reduced (down to zero, as the case may be) to take account of the benefit to Mr. Payne in the event that he receives any payments in respect of, or is able to benefit from, awards made by his previous employer under its bonus arrangements and its APSP and/or relevant malus events.

The Company confirms that, under Listing Rule 9.4.2 (2), the awards set out above do not require prior shareholder approval.

 

 

Contacts:

Polypipe Group plc

David Hall, Chief Executive Officer +44 (0) 1709 770 000

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHAKDDBPBKDDPN
Date   Source Headline
6th Apr 20213:30 pmRNSChange of Name
16th Mar 20217:00 amRNSFinal Results
11th Mar 20213:17 pmRNSHolding(s) in Company
5th Mar 20214:17 pmRNSHolding(s) in Company
3rd Mar 20219:24 amRNSHolding(s) in Company
26th Feb 20215:21 pmRNSHolding(s) in Company
26th Feb 20214:58 pmRNSTotal Voting Rights
17th Feb 20218:05 amRNSHolding(s) in Company
15th Feb 20214:22 pmRNSDirector/PDMR Shareholding
15th Feb 20211:59 pmRNSHolding(s) in Company
11th Feb 20217:00 amRNSResults of placing
10th Feb 20214:52 pmRNSProposed placing of new ordinary shares
10th Feb 20214:50 pmRNSAcquisition of ADEY
2nd Feb 20217:00 amRNSAcquisition of Nu-Heat and Trading Update
1st Feb 20213:57 pmRNSHolding(s) in Company
29th Jan 20215:32 pmRNSHolding(s) in Company
8th Jan 20218:50 amRNSHolding(s) in Company
14th Dec 20207:00 amRNSTrading Update
24th Nov 20208:25 amRNSHolding(s) in Company
17th Nov 20207:00 amRNSTrading Update
2nd Nov 20202:31 pmRNSDirector/PDMR Shareholding
2nd Nov 202010:05 amRNSBlock listing Interim Review
30th Oct 20204:26 pmRNSTotal Voting Rights
29th Oct 20202:32 pmRNSDirector/PDMR Shareholding
19th Oct 202010:09 amRNSHolding(s) in Company
7th Oct 202012:28 pmRNSHolding(s) in Company
6th Oct 202010:19 amRNSHolding(s) in Company
23rd Sep 202010:43 amRNSDirector Declaration
22nd Sep 20203:59 pmRNSDirector/PDMR Shareholding
17th Sep 20204:21 pmRNSDirector/PDMR Shareholding
15th Sep 20207:00 amRNSHalf-year Report
17th Jul 20204:26 pmRNSNon-Executive Director update
16th Jul 20209:37 amRNSHolding(s) in Company
7th Jul 20207:00 amRNSCOVID-19 Update
30th Jun 20202:41 pmRNSTotal Voting Rights
29th Jun 202012:59 pmRNSDirector Declaration
26th Jun 20204:19 pmRNSDirector/PDMR Shareholding
23rd Jun 20202:57 pmRNSDirector/PDMR Shareholding
23rd Jun 20208:28 amRNSHolding(s) in Company
22nd Jun 20204:14 pmRNSDirector/PDMR Shareholding
22nd Jun 20204:08 pmRNSDirector/PDMR Shareholding
22nd Jun 20203:06 pmRNSNon-Executive Director changes
18th Jun 20204:14 pmRNSDirector/PDMR Shareholding
17th Jun 20208:18 amRNSHolding(s) in Company
3rd Jun 202011:17 amRNSHolding(s) in Company
1st Jun 20201:24 pmRNSTotal Voting Rights
21st May 20203:05 pmRNSResult of AGM
15th May 202012:55 pmRNSHolding(s) in Company
13th May 202010:14 amRNSDirector/PDMR Shareholding
12th May 20204:01 pmRNSAnnual General Meeting 2020 - Change of Venue

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.